南方医科大学第一临床医学院//深圳市妇幼保健院新生儿科,广东 深圳 518000
黄益础,硕士生,研究方向:儿科学,E-mail:huangyichu369@163.com
纸质出版日期:2023-03-20,
收稿日期:2022-11-03,
扫 描 看 全 文
黄益础,陈雪雨,杨勇等.新生儿血清游离胆红素的测定及临床应用价值探讨[J].中山大学学报(医学科学版),2023,44(02):318-325.
HUANG Yi-chu,CHEN Xue-yu,YANG Yong,et al.Determination of Serum Unbound Bilirubin and Its Clinical Application Value in Neonates[J].Journal of Sun Yat-sen University(Medical Sciences),2023,44(02):318-325.
黄益础,陈雪雨,杨勇等.新生儿血清游离胆红素的测定及临床应用价值探讨[J].中山大学学报(医学科学版),2023,44(02):318-325. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2023.0217.
HUANG Yi-chu,CHEN Xue-yu,YANG Yong,et al.Determination of Serum Unbound Bilirubin and Its Clinical Application Value in Neonates[J].Journal of Sun Yat-sen University(Medical Sciences),2023,44(02):318-325. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2023.0217.
目的
2
探讨过氧化物酶(POD)法检测新生儿血清游离胆红素(UB)的临床适用性及应用价值。
方法
2
向胆红素标准品溶液(1、2、3 μmol/L)加入H
2
O
2
(0.33 mol/L)和三种不同终末浓度(0.019、0.038、0.075 μg/mL)的辣根过氧化物酶(HRP)以获得标准化的HRP一级速率常数Kp;新生儿血清上样量25 μL,稀释倍数41.6,于37 ℃且避光条件下用2.4、4.8 μg/mL HRP检测血清UB水平,并验证该方法学的准确性、精密度以及稳定性;收集33例黄疸患儿的一般情况及临床资料,主要包括血清总胆红素(TSB)、间接胆红素( IDB)、白蛋白(ALB)、胆红素与白蛋白摩尔比值(BAMR)等;用Graphpad Prism 8.0统计分析实验数据。
结果
2
在pH值为 7.4±0.2,反应温度37 ℃且避光条件下,标准化Kp为(7.20±1.08) mL·μg
-1
·min
-1
。HRP活性和UB水平分别于-20 ℃冻存3周和1周内无明显下降。不同UB水平血清样品的平均日内、日间变异系数均小于10%。本研究用POD法检测33例黄疸患儿(胎龄≥35周)的血清UB范围为(0.32~1.20) μg/dL,与TSB、IDB及BAMR均显著相关。有5例UB水平≥1.0 μg/dL,强光疗者占60%(3/5)。
结论
2
采用POD法结合常见设备分光光度计检测新生儿血清UB水平不仅操作简易、检测快速,且试剂成本低,具有良好的准确性和精密度,便于临床开展。血清UB的测定对新生儿黄疸的临床管理有一定的指导意义。
Objective
2
To investigate the clinical appropriateness and application value of the peroxidase (POD) method for the detection of unbound bilirubin (UB) in neonatal serum.
Methods
2
Hydrogen peroxide (0.33 mol/L) and three different final concentrations (0.019, 0.038, 0.075 μg/mL) of horseradish peroxidase (HRP) were added to standard bilirubin solution (1, 2, 3 μmol/L) to obtain a standardized HRP primary rate constant Kp. Then 25 μL of neonatal serum was diluted by 41.6 fold, and measured with 2.4 and 4.8 μg/mL HRP at 37 ℃ under the dark, to determine the UB concentration. The accuracy, precision, and stability of the methodology were validated. The clinical characteristics of 33 jaundiced neonates were collected, including total serum bilirubin (TSB), indirect bilirubin (IDB), albumin (ALB), bilirubin to albumin molar ratio (BAMR), etc. The experimental data were analyzed by Graphpad Prism 8.0.
Results
2
A standardized Kp of (7.20±1.08) mL·μg
-1
·min
-1
was determined at pH 7.4±0.2, 37 ℃ in the dark. The HRP activity and UB concentrations remained stable at -20 ℃ for 3 weeks and a week, respectively. The mean intra-day and inter-day coefficients of variation of the serum samples with different UB concentrations were less than 10%. In this study, the UB concentrations in 33 jaundiced neonates (gestational age ≥35 weeks) were measured by the POD method in the range of (0.32~1.20) μg/dL, which was positively correlated with TSB, IDB and BAMR. Of the five infants whose UB concentrations measured more than 1 μg/dL, three received intensive phototherapy (60%).
Conclusions
2
The POD method combined with a standard equipment spectrophotometer to detect serum UB concentrations in neonates is easy to operate, rapid to detect, and low cost. This method has good accuracy and precision, which is convenient for clinical implementation. Moreover, the measurement of serum UB may assist us in better management of neonatal jaundice in clinical practice.
新生儿黄疸血清游离胆红素过氧化物酶试验
neonatal jaundiceunbound bilirubinperoxidase test
Kemper AR, Newman TB, Slaughter JL, et al. Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation[J]. Pediatrics, 2022,150(3): e2022058859.
杜立中, 马晓路. 新生儿高胆红素血症诊断和治疗专家共识[J]. 中华儿科杂志, 2014,52(10):745-748.
Du LZ, Ma XL. Expert consensus on the diagnosis and treatment of neonatal hyperbilirubinemia[J]. Chin J Pediatr. 2014, 52(10):745-748.
王箫, 杜立中. 早产儿胆红素脑损伤的研究进展[J]. 中华实用儿科临床杂志, 2018,33(14):1041-1045.
Wang X, Du LZ. Research progress of bilirubin-induced brain injury in preterm neonate[J]. Chin J Appl Clin Pediatr, 2018, 33(14): 1041-1045.
Ngashangva L, Bachu V, Goswami P. Development of new methods for determination of bilirubin[J]. J Pharm Biomed Anal, 2019, 162:272-285.
Amin SB, Lamola AA. Newborn jaundice technologies: unbound bilirubin and bilirubin binding capacity in neonates[J]. Semin Perinatol, 2011, 35(3):134-140.
Jacobsen J, Wennberg RP. Determination of unbound bilirubin in the serum of newborns[J]. Clin Chem, 1974,20(7):783.
Nakamura H, Lee Y. Microdetermination of unbound bilirubin in icteric newborn sera: an enzymatic method employing peroxidase and glucose oxidase[J]. Clin Chim Acta, 1977, 79(2):411-417.
Ahlfors CE, Marshall GD, Wolcott DK, et al. Measurement of unbound bilirubin by the peroxidase test using Zone Fluidics[J]. Clin Chim Acta, 2006, 365(1-2):78-85.
Shimabuku R, Nakamura H. Total and unbound bilirubin determination using an automated peroxidase micromethod[J]. Kobe J Med, 1982, 28(2):91-104.
Roca L, Calligaris S, Wennberg RP, et al. Factors affecting the binding of bilirubin to serum albumins: validation and application of the peroxidase method[J]. Pediatr Res, 2006, 60(6):724-728.
Saluja S, Agarwal A, Kler N, et al. Auditory neuropathy spectrum disorder in late preterm and term infants with severe jaundice[J]. Int J Pediatr Otorhinolaryngol, 2010, 74(11):1292-1297.
Ahlfors CE. Effect of serum dilution on apparent unbound bilirubin concentration as measured by the peroxidase method[J]. Clin Chem(Baltimore, Md.), 1981, 27(5):692-696.
Ahlfors CE, Wennberg RP, Ostrow J D, et al. Unbound (free) bilirubin: improving the paradigm for evaluating neonatal jaundice[J]. Clin Chem, 2009,55(7):1288-1299.
Morioka I, Iwatani S, Koda T, et al. Disorders of bilirubin binding to albumin and bilirubin-induced neurologic dysfunction[J]. Semin Fetal Neonatal Med, 2015, 20(1):31-36.
Iwatani S, Yamana K, Nakamura H, et al. A novel method for measuring serum unbound bilirubin levels using glucose oxidase-peroxidase and bilirubin-inducible fluorescent protein (UnaG): No influence of direct bilirubin[J]. Int J Mol Sci, 2020, 21(18):6778.
Ahlfors CE. Predicting bilirubin neurotoxicity in jaundiced newborns[J]. Curr Opin Pediatr, 2010, 22(2):129-133.
Amin SB, Wang H. Unbound unconjugated hyperbilirubinemia is associated with central apnea in premature infants[J]. J Pediatr, 2015,166(3):571-575.
Amin SB, Wang H, Laroia N, et al. Unbound bilirubin and auditory neuropathy spectrum disorder in late preterm and term infants with severe jaundice[J]. J Pediatr, 2016, 173:84-89.
Amin SB, Saluja S, Saili A, et al. Auditory toxicity in late preterm and term neonates with severe jaundice[J]. Dev Med Child Neurol, 2017, 59(3):297-303.
Morioka I. Hyperbilirubinemia in preterm infants in Japan: New treatment criteria[J]. Pediatri int, 2018, 60(8):684-690.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation[J]. Pediatrics, 2004, 114(1):297-316.
Amin SB. Bilirubin Binding Capacity in the Preterm Neonate[J]. Clin Perinatol, 2016,43(2):241-257.
Cashore WJ. Free bilirubin concentrations and bilirubin-binding affinity in term and preterm infants[J]. J Pediatr, 1980,96(3 Pt 2):521-527.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构